Singapore secured a total of S$22.5 billion in fixed asset investments in 2022, according to the Economic Development Board on Thursday (Feb 9). Here are some of the major investments secured last year:
United Microelectronics Corporation (UMC)
US$5 billion
Electronics
The Taiwanese chipmaker UMC is setting up a new microchip factory here, with production expected to start in 2024. It will produce 22 and 28 nanometre chips to support the boom in 5G and auto electronics.
Cariflex
Over US$350 million
Chemicals
Cariflex, a subsidiary of South Korea’s DL Chemical, is building the world’s largest – and Singapore’s first – plant for polyisoprene latex, which is used in high-value medical applications such as surgical gloves and condoms. The plant on Jurong Island is the manufacturer’s largest capacity expansion to date.
Pall Corporation
US$100 million
Chemicals
United States-headquartered Pall Corporation is setting up a new manufacturing facility in Singapore, which is set to complete between late 2023 and early 2024. The new facility is expected to more than double the filtration, separation and purification supplier’s current production capacity.
Hilleman Laboratories
S$80 million
Biomedical manufacturing
Dehli-based vaccine research organisation Hilleman Laboratories broke ground on a 30,000 square feet current Good Manufacturing Practices facility last February. The new facility, together with an existing research and development facility at Biopolis, will form Singapore’s first vaccine and biologics development and manufacturing hub.
GOOD Meat
S$61 million
General manufacturing industries
GOOD Meat, the cultivated meat division of US food technology company Eat Just, will soon open a new meat production facility in Singapore. The plant is expected to have the capacity to produce “ten of thousands of pounds” of lab-grown meat per year.
